BridgeMD
New treatment option for Chronic Pain
Official title The Effect of Griffonia Simplicifolia on Pain Intensity, Central and Peripheral Sensitization, Painmodulation in Healthy Volunteers
ClinicalTrials.gov ID: NCT06893822
What this study is testing
- What it's testing
- This planned study is based on a randomized, placebo-controlled cross-over design. Griffonia simplicifolia contains the serotonin-precursor 5-hydroxytryptophan (5-HTP), an endogenous amino acid.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99. Healthy volunteers may be eligible.
You likely can't join if
- pregnancy or breastfeeding.
- renal or hepatic insufficiency
- neurological/dermatological/cardiovascular diseases
- chronic pain and/or use of analgesics
- intake of antidepressants
- intake of MAO inhibitors
See the full eligibility criteria
- pregnancy or breastfeeding.
- renal or hepatic insufficiency
- neurological/dermatological/cardiovascular diseases
- chronic pain and/or use of analgesics
- intake of antidepressants
- intake of MAO inhibitors
- intake of sleep medication
- intake of St. John's wort
- allergy to Griffonia simplicifolia
The study team makes the final eligibility decision.
Where it's taking place
- Graz, Austria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Graz, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.